Theranostics 2017; 7(7):2067-2077. doi:10.7150/thno.19427 This issue Cite

Review

Current Strategies and Challenges for Purification of Cardiomyocytes Derived from Human Pluripotent Stem Cells

Kiwon Ban1, Seongho Bae2, Young-sup Yoon2, 3✉

1. Department of Biomedical Sciences, City University of Hong Kong, Hong Kong;
2. Department of Medicine, Division of Cardiology, Emory University, Atlanta, Georgia, USA;
3. Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Korea.

Citation:
Ban K, Bae S, Yoon Ys. Current Strategies and Challenges for Purification of Cardiomyocytes Derived from Human Pluripotent Stem Cells. Theranostics 2017; 7(7):2067-2077. doi:10.7150/thno.19427. https://www.thno.org/v07p2067.htm
Other styles

File import instruction

Abstract

Graphic abstract

Cardiomyocytes (CMs) derived from human pluripotent stem cells (hPSCs) are considered a most promising option for cell-based cardiac repair. Hence, various protocols have been developed for differentiating hPSCs into CMs. Despite remarkable improvement in the generation of hPSC-CMs, without purification, these protocols can only generate mixed cell populations including undifferentiated hPSCs or non-CMs, which may elicit adverse outcomes. Therefore, one of the major challenges for clinical use of hPSC-CMs is the development of efficient isolation techniques that allow enrichment of hPSC-CMs. In this review, we will discuss diverse strategies that have been developed to enrich hPSC-CMs. We will describe major characteristics of individual hPSC-CM purification methods including their scientific principles, advantages, limitations, and needed improvements. Development of a comprehensive system which can enrich hPSC-CMs will be ultimately useful for cell therapy for diseased hearts, human cardiac disease modeling, cardiac toxicity screening, and cardiac tissue engineering.

Keywords: Cardiomyocytes, hPSCs


Citation styles

APA
Ban, K., Bae, S., Yoon, Y.s. (2017). Current Strategies and Challenges for Purification of Cardiomyocytes Derived from Human Pluripotent Stem Cells. Theranostics, 7(7), 2067-2077. https://doi.org/10.7150/thno.19427.

ACS
Ban, K.; Bae, S.; Yoon, Y.s. Current Strategies and Challenges for Purification of Cardiomyocytes Derived from Human Pluripotent Stem Cells. Theranostics 2017, 7 (7), 2067-2077. DOI: 10.7150/thno.19427.

NLM
Ban K, Bae S, Yoon Ys. Current Strategies and Challenges for Purification of Cardiomyocytes Derived from Human Pluripotent Stem Cells. Theranostics 2017; 7(7):2067-2077. doi:10.7150/thno.19427. https://www.thno.org/v07p2067.htm

CSE
Ban K, Bae S, Yoon Ys. 2017. Current Strategies and Challenges for Purification of Cardiomyocytes Derived from Human Pluripotent Stem Cells. Theranostics. 7(7):2067-2077.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.